Log in

Register Subscribe
The Home of Textile Innovation

OHIO – The US Food and Drug Administration (FDA) has granted commercial clearance for a new type of bed linen which is designed to prevent hospital patients from developing pressure ulcers. Designed by American textile manufacturing company Standard Textile, the ‘DermaTherapy’ technology is designed to channel moisture away from the skin, allowing it to be evenly distributed to evaporate over the whole surface of the bedding.

Why Subscribe?

T.EVO BACK ISSUE ARCHIVE
OTHER PUBLICATIONS FROM MCL GLOBAL

Weekly e-news bulletin

Latest news direct to your inbox

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap

 

Why Subscribe?

Looking beyond the cutting edge of textile innovation allows you to stay well ahead of the competition. That’s exactly what you get through a subscription to T.EVO – which delivers a refreshing new take on the rapid evolution of today’s dynamic textile sector.

Key T.EVO benefits:

You will learn about:

All this from MCL Global – the fastest growing international textile publisher – which can now offer today’s textile industry a unique preview of how today’s industry will look tomorrow.

In print, online and mobile device formats.